Eli Lilly and Company

Eli Lilly and Companyverified

LLY

Price:

$1014.49

Market Cap:

$911.30B

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various he...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1972-06-01

Stock Exchange

NYSE

Ticker

LLY

The Enterprise Value as of December 2025 (TTM) for Eli Lilly and Company (LLY) is 944.02B

According to Eli Lilly and Company’s latest financial reports and current stock price. The company's current Enterprise Value is 944.02B. This represents a change of 27.83% compared to the average of 738.47B of the last 4 quarters.

Eli Lilly and Company (LLY) Historical Enterprise Value (quarterly & annually)

How has LLY Enterprise Value performed in the past?

The mean historical Enterprise Value of Eli Lilly and Company over the last ten years is 262.64B. The current 944.02B Enterprise Value has changed 35.84% with respect to the historical average. Over the past ten years (40 quarters), LLY's Enterprise Value was at its highest in in the June 2024 quarter at 849.42B. The Enterprise Value was at its lowest in in the March 2016 quarter at 85.31B.

Quarterly (TTM)
Annual

Average

262.64B

Median

156.88B

Minimum

86.69B

Maximum

725.64B

Eli Lilly and Company (LLY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Eli Lilly and Company Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 58.49%

Maximum Annual Enterprise Value = 725.64B

Minimum Annual Increase = -11.03%

Minimum Annual Enterprise Value = 86.69B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024725.64B32.74%
2023546.67B51.10%
2022361.79B30.85%
2021276.48B58.49%
2020174.45B25.22%
2019139.31B14.28%
2018121.91B27.03%
201795.96B10.70%
201686.69B-11.03%
201597.44B20.59%

Eli Lilly and Company (LLY) Average Enterprise Value

How has LLY Enterprise Value performed in the past?

The current Enterprise Value of Eli Lilly and Company (LLY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

544.70B

5-year avg

417.01B

10-year avg

262.64B

Eli Lilly and Company (LLY) Enterprise Value vs. Peers

How is LLY’s Enterprise Value compared to its peers?

Eli Lilly and Company’s Enterprise Value is greater than Johnson & Johnson (475.99B), greater than AstraZeneca PLC (307.47B), greater than AbbVie Inc. (467.29B), greater than Novartis AG (279.70B), greater than Amgen Inc. (228.31B), less than Novo Nordisk A/S (1.47T), greater than Merck & Co., Inc. (276.76B), greater than Gilead Sciences, Inc. (145.58B), greater than Pfizer Inc. (206.49B), greater than Sanofi (110.77B),

CompanyEnterprise ValueMarket cap
475.99B$487.83B
307.47B$279.14B
467.29B$404.18B
279.70B$259.13B
228.31B$183.17B
1.47T$213.32B
276.76B$253.56B
145.58B$152.13B
206.49B$146.12B
110.77B$119.14B

Build a custom stock screener for Eli Lilly and Company (LLY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eli Lilly and Company using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eli Lilly and Company (LLY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eli Lilly and Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Eli Lilly and Company's Enterprise Value?

What is the highest Enterprise Value for Eli Lilly and Company (LLY)?

What is the 3-year average Enterprise Value for Eli Lilly and Company (LLY)?

What is the 5-year average Enterprise Value for Eli Lilly and Company (LLY)?

How does the current Enterprise Value for Eli Lilly and Company (LLY) compare to its historical average?